The Safety of Opioid Use in Chronic Obstructive Pulmonary Disease
hosted byConnect Educate Impact (CEI)
The Safety of Opioid Use in Chronic Obstructive Pulmonary Disease is organized by Connect Educate Impact (CEI).
Initial Release Date: May 12, 2021
Planned Expiration Date: May 12, 2024
Description:
May's Journal Club features a study discussing the association between transient opioid use and short-term respiratory exacerbation in patients with COPD. Learn the pros and cons related to clinical outcomes and safety, as discussed in the GOLD Guidelines and other documented trials.
Objectives:
Upon successful completion of this application-based course, pharmacists and pharmacy students should be able to:
• Discuss existing guidelines for the treatment of dyspnea among patients with Chronic Obstructive Pulmonary Disease (COPD)
• Evaluate the strengths of evidence from various existing studies
• Interpret the findings of Rong et al., 2019 and draw conclusions for clinical practice
• Describe the applicability, strengths, and limitations of case-crossover designs
• Identify avenues for future research to improve our understanding of opioid use among patients with COPD